Daniel Arias
Stock Analyst at Stifel
(5.00)
# 3
Out of 5,090 analysts
161
Total ratings
61.29%
Success rate
146.86%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Buy | $145 | $108.00 | +34.26% | 1 | Dec 1, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,412.03 | +13.31% | 8 | Nov 10, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $67 → $80 | $101.16 | -20.92% | 7 | Nov 4, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $70 | $103.70 | -32.50% | 4 | Sep 25, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $47.61 | -15.98% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $10.99 | +9.19% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $101.73 | +8.13% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $62.19 | -3.52% | 11 | May 8, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $569.98 | +8.78% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $225.12 | +15.49% | 10 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.48 | +508.11% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $17.57 | +2.45% | 6 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $6.37 | -5.81% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $76.87 | -15.44% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $394.47 | -8.74% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $145.20 | +3.99% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $47.05 | -1.49% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.73 | +168.46% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $164.23 | +26.04% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $128.22 | +55.98% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.77 | +182.49% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $3.50 | +186.12% | 2 | May 31, 2022 |
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $108.00
Upside: +34.26%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,412.03
Upside: +13.31%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $67 → $80
Current: $101.16
Upside: -20.92%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $60 → $70
Current: $103.70
Upside: -32.50%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $47.61
Upside: -15.98%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $10.99
Upside: +9.19%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $101.73
Upside: +8.13%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $62.19
Upside: -3.52%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $569.98
Upside: +8.78%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $225.12
Upside: +15.49%
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.48
Upside: +508.11%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $17.57
Upside: +2.45%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.37
Upside: -5.81%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $76.87
Upside: -15.44%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $394.47
Upside: -8.74%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $145.20
Upside: +3.99%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $47.05
Upside: -1.49%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.73
Upside: +168.46%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $164.23
Upside: +26.04%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $128.22
Upside: +55.98%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $1.77
Upside: +182.49%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $3.50
Upside: +186.12%